NO20054158L - Kombinert anvendelse av ribavirin og interferon beta ved demyeliserende sykdommer - Google Patents

Kombinert anvendelse av ribavirin og interferon beta ved demyeliserende sykdommer

Info

Publication number
NO20054158L
NO20054158L NO20054158A NO20054158A NO20054158L NO 20054158 L NO20054158 L NO 20054158L NO 20054158 A NO20054158 A NO 20054158A NO 20054158 A NO20054158 A NO 20054158A NO 20054158 L NO20054158 L NO 20054158L
Authority
NO
Norway
Prior art keywords
ribavirin
combined use
interferon beta
demyelating diseases
demyelating
Prior art date
Application number
NO20054158A
Other languages
English (en)
Inventor
Giampiero De Luca
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of NO20054158L publication Critical patent/NO20054158L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Den foreliggende oppfinnelse er i området nevrologiske hdelser. Den angår anvendelse av en forbindelse med formel (I) i kombinasjon med et interferon (IFN) til fremstilling av et legemiddel for behandling og/eller forhindring av en demyelinerende sykdom. Særlig angår den anvendelse av en kombinasjon av ribavirin og IFNbeta til behandling og/eller forhindring av en demyelinerende sykdom, så som multippel sklerose.
NO20054158A 2003-02-25 2005-09-07 Kombinert anvendelse av ribavirin og interferon beta ved demyeliserende sykdommer NO20054158L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03100459 2003-02-25
PCT/EP2004/050202 WO2004075903A1 (en) 2003-02-25 2004-02-24 Combined use of ribavirin and interferon beta in demyelinating diseases

Publications (1)

Publication Number Publication Date
NO20054158L true NO20054158L (no) 2005-09-07

Family

ID=32921601

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20054158A NO20054158L (no) 2003-02-25 2005-09-07 Kombinert anvendelse av ribavirin og interferon beta ved demyeliserende sykdommer

Country Status (12)

Country Link
US (1) US20060276419A1 (no)
EP (1) EP1596873A1 (no)
JP (1) JP2006518725A (no)
KR (1) KR20060002758A (no)
CN (1) CN1761471A (no)
AU (1) AU2004216485B2 (no)
BR (1) BRPI0407781A (no)
CA (1) CA2515210A1 (no)
EA (1) EA010801B1 (no)
MX (1) MXPA05008998A (no)
NO (1) NO20054158L (no)
WO (1) WO2004075903A1 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2263678B1 (en) * 2004-12-22 2014-06-11 Merck Serono SA Cladribine regimen for treating early secondary progressive Multiple Sclerosis
US20080260690A1 (en) * 2005-11-18 2008-10-23 Ares Trading S.A. Interferon in Influenza
US9925151B2 (en) 2006-05-24 2018-03-27 Merck Serono Sa Cladribine regimen for treating multiple sclerosis
EP2076533B1 (en) 2007-05-02 2014-10-08 Ambrx, Inc. Modified interferon beta polypeptides and their uses
US10374993B2 (en) 2017-02-20 2019-08-06 Snap Inc. Media item attachment system
EA035792B1 (ru) * 2018-06-21 2020-08-11 Государственное Научное Учреждение "Институт Биоорганической Химии Национальной Академии Наук Беларуси" Лекарственное средство пролонгированного действия для лечения рассеянного склероза (варианты)
US11265281B1 (en) 2020-01-28 2022-03-01 Snap Inc. Message deletion policy selection

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4307883A1 (en) * 1992-03-12 1993-09-23 Westarp Martin Egon Dr Med Use of anti-retroviral substances - to treat motor-neuronal diseases
EP1302474A1 (en) * 1996-10-16 2003-04-16 Ribapharm, Inc. Monocyclic L-nucleosides, analogs and uses thereof
AU2026900A (en) * 1998-11-20 2000-06-13 Salk Institute For Biological Studies, The Neuron stimulation by ribavirin, and analogs thereof
US6495677B1 (en) * 2000-02-15 2002-12-17 Kanda S. Ramasamy Nucleoside compounds

Also Published As

Publication number Publication date
US20060276419A1 (en) 2006-12-07
KR20060002758A (ko) 2006-01-09
EA200501344A1 (ru) 2006-02-24
WO2004075903A1 (en) 2004-09-10
JP2006518725A (ja) 2006-08-17
EA010801B1 (ru) 2008-12-30
EP1596873A1 (en) 2005-11-23
AU2004216485B2 (en) 2009-06-11
AU2004216485A1 (en) 2004-09-10
MXPA05008998A (es) 2005-10-18
CA2515210A1 (en) 2004-09-10
BRPI0407781A (pt) 2006-02-14
CN1761471A (zh) 2006-04-19

Similar Documents

Publication Publication Date Title
NO20054158L (no) Kombinert anvendelse av ribavirin og interferon beta ved demyeliserende sykdommer
WO2006122011A3 (en) Thiazole compounds and methods of use
WO2005007681A3 (en) Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
WO2006039488A3 (en) Hcv ns3-ns4a protease inhibition
WO2005037860A3 (en) Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
MXPA05005379A (es) Tioureas de arilo sustituidas y compuestos relacionados; inhibidores de duplicacion viral.
WO2005067900A3 (en) Azabenzofuran substituted thioureas as inhibitors of viral replication
EA200300776A1 (ru) Производные фенэтаноламина для лечения респираторных заболеваний
UA85708C2 (ru) Лекарственные комбинации, содержащие бензоксазины, для лечения заболеваний дыхательных путей
EA200701296A1 (ru) 3,5-дизамещенные и 3,5,7-тризамещенные 3h-оксазоло- и 3h-тиазоло[4,5-d] пиримидин-2-оны и их пролекарства
TW200600492A (en) Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
EP2311851A3 (en) Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
MY148123A (en) Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
ATE465164T1 (de) Triazolopyrazinverbindungen zur behandlung von degenerations- und entzündungskrankheiten
WO2003096990A3 (en) Protein cages for the delivery of medical imaging and therapy
WO2005095345A3 (en) Heteroaryl guanidines as inhibitors of viral replication
EA200601846A1 (ru) Содержащие бензоксазины лекарственные комбинации для лечения заболеваний дыхательных путей
WO2007014943A3 (en) Therapy for neurological diseases
TNSN06403A1 (en) 3-B-D-RIBOFURANOSYLTHIAZOLO[4,5-d]PYRIDIMINE NUCLEOSIDES AND USES THEREOF
WO2005037798A3 (en) Amide or thiomide derivatives and their use in the treatment of pain
GB0130677D0 (en) Medicaments and novel compounds
HK1079526A1 (en) A novel pyrazine compound and its use in the manufacture of a medicament for treating diseases related to serotonin
EA200701615A1 (ru) Новые лекарственные средства для лечения заболеваний дыхательных путей
DE602004014728D1 (de) Behandlung von durch das ljungan-virus ausgelösten erkrankungen durch verwendung von pleconaril
MY143775A (en) Compound having anti-hcv action

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: ONSAGERS AS, POSTBOKS 6963 ST OLAVS PLASS, 0130 OS

FC2A Withdrawal, rejection or dismissal of laid open patent application